Related Experiment Video
Updated: Feb 13, 2026

Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
Bezafibrate prolongs hypothermia induced by an A1 adenosine receptor agonist in CBA/N mice
Miho Sato-Hashimoto1, Hiroshi Ohnishi2,3
1Department of Animal Pharmaceutical Science, School of Pharmaceutical Sciences, Kyushu University of Medical Science, Miyazaki, Japan.
Abstract:
Understanding thermoregulation within the range of low body temperatures (Tb) in homeotherms is of special interest in various life science fields. Here, we report that mice exhibit long-lasting hypothermia induced by the administration of an A1 adenosine receptor (A1AR) agonist, N6-cyclohexyladenosine (CHA), in combination with pretreatment with bezafibrates (BZ), a peroxisome proliferator-activated receptor α (PPARα) agonist. Before the induction of hypothermia by CHA administration at a dose of 0.5 mg/kg, CBA/N mice were fed 0.5% BZ-supplemented food for 10 days at an ambient temperature of 23-24°C. Ten days after BZ treatment, intraperitoneal CHA administration induced low Tb (<33°C) lasting for 6 hr, while mice provided the control food without BZ supplementation experienced low Tb lasting for <1 hr after CHA administration. The combined administration of these drugs also marked decreased oxygen consumption, carbon dioxide output, and energy expenditure compared with those in control mice that received CHA injections alone. These findings demonstrate that BZ-induced PPARα activation enhanced the sensitivity of A1AR, thereby prolonging low Tb. Both receptors are considered key factors in controlling torpor and/or hibernation; however, a synergistic relationship between these receptors has not been reported. Therefore, our findings suggest that metabolic activation of lipid catabolism via PPARα signaling may potentiate the hypothermic effects induced by A1AR activation.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Internal Receptors
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...

